India Biotech needs more information on Covasin: WHO: Amore

New York, 25 May

The World Health Organization (WHO) has said it needs more information from India Biotech, which is seeking permission to include its covasin vaccine in its “Emergency Use List” for the treatment of Kovid-19. According to the latest guidance document posted on the organization’s website on 18 May, Bharat Biotech filed an EOI (expression of interest) on 19 April. The organization said more information is needed from the company. According to the document, a meeting is expected in May-June 2021. According to the WHO, documents submitted for pre-qualification for approval of the vaccine or for inclusion in the ‘Emergency Use List’ are kept confidential. -PTI

Related Articles

Back to top button